On February 8, 2022, Denovicon Therapeutics Founder & CEO, Scott Bembenek will talk (along with BIOVIA’s Ton van Daelen) at SLAS 2022 about how AI and the use of virtual–real cycles is changing the drug discovery process.
On February 8, 2022, Denovicon Therapeutics Founder & CEO, Scott Bembenek will talk (along with BIOVIA’s Ton van Daelen) at SLAS 2022 about how AI and the use of virtual–real cycles is changing the drug discovery process.